ID: ALA3771075

Max Phase: Preclinical

Molecular Formula: C16H14O7

Molecular Weight: 318.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(O)ccc1C1Oc2cc(O)cc(O)c2C(=O)C1O

Standard InChI:  InChI=1S/C16H14O7/c1-22-11-5-7(17)2-3-9(11)16-15(21)14(20)13-10(19)4-8(18)6-12(13)23-16/h2-6,15-19,21H,1H3

Standard InChI Key:  MDNDRVOVCSEAMC-UHFFFAOYSA-N

Associated Targets(non-human)

Prostaglandin E synthase 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.28Molecular Weight (Monoisotopic): 318.0740AlogP: 1.49#Rotatable Bonds: 2
Polar Surface Area: 116.45Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.75CX Basic pKa: CX LogP: 1.96CX LogD: 1.80
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.66Np Likeness Score: 2.16

References

1. Chen Y, Liu H, Xu S, Wang T, Li W.  (2015)  Targeting microsomal prostaglandin E2synthase-1 (mPGES-1): the development of inhibitors as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs),  (12): [10.1039/C5MD00278H]

Source